News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2023-09-11 1:31:4 pm Arbutus Announces Pipeline Updates and Dosing of the First Subject in the Phase 1a/1b Clinical Trial with AB-101; Cash Runway Extended GlobeNewsWire
2023-09-11 1:15:0 pm Arbutus Announces Pipeline Updates and Dosing of the First Subject in the Phase 1a/1b Clinical Trial with AB-101; Cash Runway Extended GlobeNewswire
2023-09-07 4:30:0 am Arbutus to Participate in Two Upcoming Investor Conferences GlobeNewswire
2023-08-26 7:41:25 am Arbutus Biopharma (NASDAQ:ABUS) shareholders have endured a 78% loss from investing in the stock five years ago Simply Wall St.
2023-08-04 12:29:0 pm Arbutus Biopharma Corporation (NASDAQ:ABUS) Q2 2023 Earnings Call Transcript Insider Monkey
2023-08-03 5:55:16 am Arbutus Biopharma (ABUS) Reports Q2 Loss, Lags Revenue Estimates Zacks
2023-08-03 4:49:11 am Arbutus: Q2 Earnings Snapshot AP Finance
2023-08-03 4:30:0 am Arbutus Reports Second Quarter 2023 Financial Results and Corporate Update GlobeNewswire
2023-07-23 7:19:8 am Arbutus Biopharma Corporation (NASDAQ:ABUS) has caught the attention of institutional investors who hold a sizeable 38% stake Simply Wall St.
   

Please consider a small donation if you think this website provides you with relevant information